Conference Report
The 28th Annual Meeting of The Japanese Society of Female Pelvic Floor Medicine @Gifu, Japan
We exhibited at the 28th Annual Meeting of the Japan Society of Female Pelvic Floor Medicine, held at the Nagaragawa Convention Center in Gifu, Japan, on July 25-26, 2026.
On July 25, we co-hosted the luncheon seminar "New Wave 2026 in Mesh Surgery for Pelvic Organ Prolapse ," chaired by Dr. Masami Takeyama of Daiichi Towakai Hospital. The seminar attracted a large audience of surgeons and was a great success.
The first lecture, "A New Era of TVM: Toward the Standardization of vNOTES-TVM," was presented by Dr. Kosei Miwa from the Department of Urology and Urogynecology Center, Japanese Red Cross Gifu Hospital.
Dr. Miwa discussed the challenges faced by surgeons when introducing transvaginal mesh (TVM) surgery for pelvic organ prolapse, including the risk of bleeding caused by tissue dissection that cannot be seen directly, the risk of organ injury, and the need to rely on touch of the surgeon's hands to identify key anatomical structures.
To address these challenges, he presented his ongoing efforts to establish TVM techniques based on the vNOTES approach and to improve surgical instruments. He also emphasized that careful confirmation by touch is essential for performing a safe surgery, even when the site is visible via endoscopy.
The second lecture, "Training and Safety Measures for Robot-assisted Sacrocolpopexy (RSC): What is ORIHIME?" was presented by Dr. Satoshi Tanimura from the Department of Obstetrics and Gynecology, Toyama Prefectural Central Hospital.
Dr. Tanimura explained that approximately half of all pelvic organ prolapse surgeries performed in Japan in 2024 were sacrocolpopexy procedures, and the over half of those were robot-assisted sacrocolpopexy (RSC). He also highlighted that Japan's 2026 reimbursement revision introduced additional reimbursement for endoscopic surgical assistance system, including RSC. This policy is expected to encourage more hospitals to adopt RSC in the coming years.
The presentation emphasized that the safe adoption of RSC requires structured training programs, comprehensive safety measures, and a thorough understanding of the material characteristics of mesh. In addition, surgeons should carefully evaluate surgical indications and develop comprehensive treatment strategies that also consider non-mesh surgical options.
The congress reflected the growing interest in RSC. ORIHIME, our PTFE mesh, was also featured in numerous scientific presentations, indicating its expanding adoption in many hospitals.
At our exhibition booth, we showcased ORIHIME PTFE Mesh for pelvic organ prolapse surgery together with our sutures, including ASFLEX and TEFDESSER II.
We would like to express our sincere gratitude to everyone who attended our luncheon seminar and visited our booth. We truly appreciate your continued interest and support.
For the latest updates on our conference activities and products, please follow us on our social media channels.
Facebook：https://www.facebook.com/CROWNJUN
LinkedIn：https://www.linkedin.com/company/crownjunkono/
Instagram：https://www.instagram.com/crownjun_kono/
